PORTLAND, Maine–(BUSINESS WIRE)–January 26, 2022–
Covetrus ® (NASDAQ: CVET), a global leader in animal health technologies and services, today announced the appointment of César França as President, Global Proprietary Brands.
França will lead the company-wide development and management of Covetrus’ global portfolio of proprietary brands, including current brands Covetrus, Kruuse, Vi, Roadrunner Pharmacy and Calibra. The company will rely on its vision and expertise to develop categories, build strategic partnerships and identify opportunities for external growth.
França brings more than 25 years of leadership and experience in brand development and management, marketing, sales, business development and general management to Covetrus.
“We are delighted to welcome Cesar to this dynamic new role,” said Matt Malenfant, Chief Commercial Officer at Covetrus. “César is a positive and trusted leader with a fundamental belief in the power of people and brands. He will work closely with our commercial and operations teams to ensure efficiency and execution across all regional business units as we continue to help veterinarians improve their health and business results.
França spent the last 20 years of her career at Nestlé SA, the largest food company in the world, with more than 2,000 brands sold in 186 countries around the world. At Nestlé SA, he held various management positions, leading the development of a wide range of brands in various product categories. Throughout her impressive career, França has redesigned portfolios, reinvigorated brands and set strategic priorities to drive sustainability and profitability.
“I am thrilled to join the Covetrus team and lead the development of the most sought after, loved and iconic brands in the animal health industry – for both veterinarians and pet parents. “, France said.
Covetrus is a global animal health technology and services company dedicated to empowering partners in veterinary practice to improve health and bottom line results. We bring together products, services and technologies in a single platform that connects our customers to the solutions and information they need to operate at their best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, and has more than 5,500 employees serving more than 100,000 customers worldwide. For more information about Covetrus, visit https://covetrus.com/.
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which involve risks and uncertainties, including including statements about our plans, goals, expectations and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and outlook are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on the current beliefs and expectations of our management team and, except as required by law, we do not undertake to make any changes to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this press release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220126005183/en/
KEYWORD: MAINE UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: VETERINARY HEALTH
Copyright BusinessWire 2022.
PUBLISHED: 01/26/2022 09:00/DISC: 01/26/2022 09:03
Copyright BusinessWire 2022.